Particularly, radotinib protects against α-synuclein preformed fibrils (PFF)-induced neuronal cell death and restores α-synuclein PFF-induced activation of Iba-1-positive microglia and GFAP-positive astrocytes in Parkinson’s disease models. This evidence concerns the gene GFAP and Parkinson disease.